Central Asset Investments & Management Holdings’s Astera Labs ALAB Stock Holding History

Central Asset Investments & Management Holdings’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.61M	Buy	+7,477	New	+$1.98M	1.43%	9

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Central Asset Investments & Management Holdings's ALAB Position: Q2 2026 in Review

Central Asset Investments & Management Holdings opened a new position in Astera Labs (ALAB) in Q2 2026: 7,477 shares worth $3.61M. The stake represents 1.43% of the portfolio and ranks #9 among its holdings.

653 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Central Asset Investments & Management Holdings held 7,477 shares of Astera Labs worth $3.61M as of Q2 2026.
Astera Labs was a new Central Asset Investments & Management Holdings position in Q2 2026.
Astera Labs made up 1.43% of Central Asset Investments & Management Holdings's portfolio in Q2 2026, its #9 holding.
653 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Central Asset Investments & Management Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.